Clinical trial
The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice
NCT02577445 · LivaNova, Industry · Terminated
Key facts
| NCT number | NCT02577445 |
|---|---|
| Title | The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice |
| Official title | The remedē® System (Respiratory Rhythm Management™ Device) for the Treatment of Central Sleep Apnea in Daily Practice |
| Acronym | TREAT-CSA |
| Lead sponsor | LivaNova, Industry |
| Collaborators | Respicardia, Inc. Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Sleep Apnea, Central Sleep Disordered Breathing |
| Enrollment | 31 |
| Start date | Feb 1, 2016 |
| Primary completion | Oct 1, 2016 |
| Completion | Oct 1, 2016 |
| First posted | Oct 16, 2015 |
| Last update posted | Apr 6, 2017 |
| Countries | Germany, Spain |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: